Khayata M, Al-Kindi SG, Oliveira GH. Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. World J Cardiol 2019; 11(1): 38-46 [PMID: 30705741 DOI: 10.4330/wjc.v11.i1.38]
Corresponding Author of This Article
Guilherme H Oliveira, MD, FACC, Associate Professor, Section of Heart Failure and Transplant, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, United States. guilherme.oliveira@uhhospitals.org
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jan 26, 2019; 11(1): 38-46 Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.38
Table 1 Baseline characteristics by etiology n (%)
NICM (n = 8416)
FDCM (n = 677)
P value
ICM (n = 8301)
P value
Age at listing
50.9 ± 12.3
43.9 ± 13.5
< 0.001
58.5 ± 8.1
< 0.001
Male gender
6113 (72.6)
444 (65.6)
< 0.001
7212 (86.9)
< 0.001
Ethnicity
< 0.001
< 0.001
White
4609 (54.8)
444 (65.6)
6411 (77.2)
Black
2776 (33.0)
159 (23.5)
976 (11.8)
Hispanic
705 (8.4)
54 (8.0)
575 (6.9)
Asian
223 (2.6)
14 (2.1)
269 (3.2)
Other or unknown
103 (1.2)
6 (0.9)
70 (0.8)
Initial status
< 0.001
0.956
1A
1918 (22.8)
147 (21.7)
1823 (22.0)
1B
4023 (47.8)
273 (40.3)
3415 (41.1)
2
2227 (26.5)
238 (35.2)
2831 (34.1)
7
248 (2.9)
19 (2.8)
232 (2.8)
Therapies
Inotropes
2947 (35)
233 (34.4)
0.769
2386 (28.7)
0.002
ECMO
52 (0.6)
4 (0.6)
1.0
87 (1.0)
0.320
IABP
395 (4.7)
21 (3.1)
0.056
403 (4.9)
0.038
Mechanical ventilation
141 (1.7)
10 (1.5)
0.875
209 (2.5)
0.118
LVAD
2104 (25.1)
124 (18.4)
< 0.001
2116 (25.6)
< 0.001
BiVAD
153 (1.8)
8 (1.2)
0.288
157 (1.9)
0.233
TAH
50 (0.6)
9 (1.3)
0.039
31 (0.4)
0.002
ICD
6985 (83.5)
562 (83.8)
0.914
6652 (80.9)
0.073
Laboratory values
Creatinine
1.4 ± 1.0
1.3 ± 0.7
0.008
1.4 ± 0.9
< 0.001
Albumin
3.7 ± 0.7
3.8 ± 0.6
0.001
3.7 ± 0.7
0.001
Bilirubin
1.1 ± 1.8
1.1 ± 1.0
0.578
1.0 ± 2.0
0.540
PRA class I
7.1 ± 18.6
7.2 ± 18.5
0.892
5.7 ± 16.2
0.084
PRA class II
4.8 ± 15.7
5.2 ± 16.2
0.645
3.4 ± 12.6
0.012
Hemodynamics
PA systolic pressure (mmHg)
44.3 ± 13.9
42.7 ± 13.2
0.004
44.8 ± 15.2
0.001
PA diastolic pressure (mmHg)
22.1 ± 8.9
21.7 ± 8.7
0.266
20.8 ± 8.6
0.013
PA mean pressure (mmHg)
30.5 ± 10.2
29.7 ± 9.8
0.052
29.8 ± 10.5
0.821
PCWP (mmHg)
20.5 ± 9.0
20.4 ± 8.5
0.735
19.7 ± 8.9
0.081
CO (L/min)
4.3 ± 1.4
4.1 ± 1.3
0.011
4.5 ± 1.3
< 0.001
Table 2 Wait-list outcomes by etiology
Outcome
FDCM vs NICM
FDCM vs ICM
HR (95%CI), P value
HR (95%CI), P value
Waitlist mortality
0.720 [0.507-1.023], P = 0.067
0.609 [0.429-0.864], P = 0.005
Delisting due to deterioration
0.499 [0.319-0.781], P = 0.002
0.387 [0.248-0.604], P < 0.001
Waitlist mortality or delisting due to deterioration
0.617 [0.468-0.813], P = 0.001
0.501 [0.381-0.659], P = 0.001
Delisting due to improvement
0.277 [0.131-0.588], P = 0.001
0.347 [0.163-0.735], P = 0.006
Transplant
1.248 [1.135-1.373], P < 0.001
1.183 [1.076-1.302], P = 0.001
Table 3 Determinants of wait-list mortality or delisting
Univariable HR (95%CI)
P value
Multivariable HR (95%CI)
P value
Age at listing
0.082
Gender
0.413
Ethnicity
0.712
UNOS listing status
< 0.001
0.001
1b vs 1a
0.431 [0.231-0.805]
0.606 [0.305-1.204]
2 vs 1a
0.160 [0.073-0.350]
0.176 [0.073-0.424]
7 vs 1a
0.852 [0.252-2.886]
1.326 [0.373-4.707]
Inotropes
0.110
ECMO
0.229
IABP
3.987 [1.575-10.090]
0.004
0.124
Mechanical Ventilation
4.294 [1.333-13.831]
0.015
3.694 [1.022-13.360]
0.046
VAD
0.009
0.519
LVAD vs no VAD
1.084 [0.540-2.179]
BiVAD vs no VAD
7.636 [2.342-24.900]
TAH vs no VAD
1.724 [0.236-12.600]
ICD
0.392
Creatinine
1.275 [1.142-1.422]
< 0.001
1.377 [1.211-1.566]
< 0.001
PASP
1.022 [1.002-1.043]
0.033
0.169
PADP
0.067
PAMP
0.097
PCWP
0.387
CO
0.093
List year
0.282
Table 4 Post-transplantation outcomes n (%)
NICM
FDCM
P-value
ICM
P value
Stroke
114 (2.3)
6 (1.4)
0.239
147 (3.0)
0.051
Permanent pacemaker
171 (3.4)
16 (3.6)
0.785
164 (3.3)
0.681
Treated for rejection
496 (9.8)
51 (11.4)
0.283
416 (8.4)
0.034
Dialysis
476 (9.5)
43 (9.7)
0.866
507 (10.2)
0.806
LOS (d)
19 ± 22
17.3 ± 13.1
0.105
20.7 ± 25.4
0.006
Citation: Khayata M, Al-Kindi SG, Oliveira GH. Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. World J Cardiol 2019; 11(1): 38-46